LUPIN.NS Profit & Loss
Lupin Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:36
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹16,641.66 Cr. | ₹20,010.82 Cr. | ₹22,707.90 Cr. | ₹27,958.03 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | ₹20,010.82 Cr. | ₹22,707.90 Cr. | ₹27,958.03 Cr. | SegmentRevenueFromOperations |
| Other Income | ₹73.36 Cr. | ₹120.17 Cr. | ₹195.82 Cr. | ₹424.45 Cr. | OtherIncome |
| Total Income | ₹16,715.02 Cr. | ₹20,130.99 Cr. | ₹22,903.72 Cr. | ₹28,382.48 Cr. | Income |
| Cost of Materials Consumed | ₹3,687.81 Cr. | ₹4,142.19 Cr. | ₹4,457.41 Cr. | ₹4,621.90 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹2,938.22 Cr. | ₹2,958.72 Cr. | ₹2,642.62 Cr. | ₹2,867.01 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹153.73 Cr. | ₹-457.44 Cr. | ₹-257.78 Cr. | ₹-162.45 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹3,087.15 Cr. | ₹3,494.57 Cr. | ₹3,964.20 Cr. | ₹4,574.53 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹274.30 Cr. | ₹311.61 Cr. | ₹294.87 Cr. | ₹434.49 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹880.69 Cr. | ₹1,196.81 Cr. | ₹1,169.26 Cr. | ₹1,375.50 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹4,976.63 Cr. | ₹6,062.26 Cr. | ₹6,618.14 Cr. | ₹7,241.04 Cr. | OtherExpenses |
| Total Expenses | ₹15,998.53 Cr. | ₹17,708.72 Cr. | ₹18,888.72 Cr. | ₹20,952.02 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹716.49 Cr. | ₹2,422.27 Cr. | ₹4,015.00 Cr. | ₹7,430.46 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹-557.91 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹716.49 Cr. | ₹2,422.27 Cr. | ₹4,015.00 Cr. | ₹6,872.55 Cr. | ProfitBeforeTax |
| Tax Expense | ₹268.80 Cr. | ₹486.70 Cr. | ₹708.74 Cr. | ₹1,517.08 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹447.69 Cr. | ₹1,935.57 Cr. | ₹3,306.26 Cr. | ₹5,355.47 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹430.08 Cr. | ₹1,914.48 Cr. | ₹3,281.62 Cr. | ₹5,332.84 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹9.46 | ₹42.05 | ₹71.95 | ₹116.75 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹9.41 | ₹41.87 | ₹71.69 | ₹116.44 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from LUPIN.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).